HMS174 strains provide the recA mutation in a K-12 background. Like BLR, these strains may stabilize certain target genes whose products may cause the loss of the DE3 prophage.
Legal Information: NOVAGEN is a registered trademark of Merck KGaA, Darmstadt, Germany